Epidemiology and molecular characterization of macrolide-resistant Streptococcus pyogenes in Taiwan

Journal of Clinical Microbiology

Volumn 52, Issue 2, 2014, Pages 508-516

  Huang, Chia Ying ^a   Lai, Jui Fen ^a   Huang, I Wen ^a   Chen, Pei Chen ^a   Wang, Hui Ying ^a   Shiau, Yih Ru ^a   Cheng, Ya Wen ^b   Hsieh, Li Yun ^a   Chang, Shan Chwen ^b   Yang Lauderdale, Tsai Ling ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; LINEZOLID; MACROLIDE; PENICILLIN DERIVATIVE; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHILD; GROUP A STREPTOCOCCAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STREPTOCOCCUS PYOGENES; TAIWAN; THROAT CULTURE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; DNA FINGERPRINTING; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MACROLIDES; MALE; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PHENOTYPE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TAIWAN;

EID: 84893067223     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02383-13     Document Type: Article

References (36)

1. Bisno AL, Brito MO, Collins CM. 2003. Molecular basis of group A streptococcal virulence. Lancet Infect. Dis. 3:191-200. http://dx.doi.org/10. 1016/S1473-3099(03)00576-0.
2. Carapetis JR, Steer AC, Mulholland EK, Weber M. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5:685-694. http://dx.doi.org/10.1016/S1473-3099(05)70267-X.
3. Beall B, Facklam R, Thompson T. 1996. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J. Clin. Microbiol. 34:953-958.
4. Steer AC, Law I, Matatolu L, Beall BW, Carapetis Jr. 2009. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect. Dis. 9:611-616. http://dx.doi.org/10. 1016/S1473-3099(09)70178-1.
5. Silva-Costa C, Friães A, Ramirez M, Melo-Cristino J, Portuguese Group for the Study of Streptococcal Infections. 2012. Differences between macrolide-resistant and-susceptible Streptococcus pyogenes: importance of clonal properties in addition to antibiotic consumption. Antimicrob. Agents Chemother. 56:5661-5666. http://dx.doi.org/10.1128/AAC.01133-12.
6. Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C. 2012. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 55:1279-1282. http://dx.doi.org/10.1093/cid/cis847.
7. Bingen E, Bidet P, Mihaila-Amrouche L, Doit C, Forcet S, Brahimi N, Bouvet A, Cohen R. 2004. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children. Antimicrob. Agents Chemother. 48:3559-3562. http://dx.doi.org/10.1128/AAC.48.9.3559-3562.2004.
8. Hsueh PR, Shyr JM, Wu JJ. 2005. Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan. Clin. Infect. Dis. 40:903-905. http://dx.doi.org/10.1086/427946.
9. Bergman M, Huikko S, Pihlajamaki M, Laippala P, Palva E, Huovinen P, Seppala H. 2004. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin. Infect. Dis. 38:1251-1256. http://dx.doi.org/10.1086/383309.
10. d'Humieres C, Cohen R, Levy C, Bidet P, Thollot F, Wollner A, Bingen E. 2012. Decline in macrolide-resistant Streptococcus pyogenes isolates from French children. Int. J. Med. Microbiol. 302:300-303. http://dx.doi.org/10.1016/j. ijmm.2012.09.001.
11. Van Heirstraeten L, Coenen S, Lammens C, Hens N, Goossens H, Malhotra-Kumar S. 2012. Antimicrobial drug use and macrolideresistant Streptococcus pyogenes, Belgium. Emerg. Infect. Dis. 18:1515-1518. http://dx.doi.org/10.3201/eid1809.120049.
12. Giovanetti E, Brenciani A, Lupidi R, Roberts MC, Varaldo PE. 2003. Presence of the tet(O) gene in erythromycin-and tetracycline-resistant strains of Streptococcus pyogenes and linkage with either the mef(A) or the erm(A) gene. Antimicrob. Agents Chemother. 47:2844-2849. http://dx.doi.org/10.1128/AAC.47.9. 2844-2849.2003.
13. Seppala H, Skurnik M, Soini H, Roberts MC, Huovinen P. 1998. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42:257-262. http://dx.doi.org/10.1093/jac/42.2. 257.
14. Ho M, McDonald LC, Lauderdale TL, Yeh LL, Chen PC, Shiau YR. 1999. Surveillance of antibiotic resistance in Taiwan, 1998. J. Microbiol. Immunol. Infect. 32:239-249.
15. Hsueh PR, Chen HM, Huang AH, Wu JJ. 1995. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob. Agents Chemother. 39:2239-2242. http://dx.doi.org/10.1128/AAC.39.10.2239.
16. Ho M, Hsiung CA, Yu HT, Chi CL, Chang HJ. 2004. Changes before and after a policy to restrict antimicrobial usage in upper respiratory infections in Taiwan. Int. J. Antimicrob. Agents 23:438-445. http://dx.doi.org/10.1016/j. ijantimicag.2003.10.013.
17. Chen FJ, Huang IW, Wang CH, Chen PC, Wang HY, Lai JF, Shiau YR, Lauderdale TL. 2012. mecA-positive Staphylococcus aureus with low-level oxacillin MIC in Taiwan. J. Clin. Microbiol. 50:1679-1683. http://dx.doi.org/10. 1128/JCM.06711-11.
18. McDonald LC, Lauderdale TL, Shiau YR, Chen PC, Lai JF, Wang HY, Ho M. 2004. The status of antimicrobial resistance in Taiwan among Gram-positive pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme, 2000. Int. J. Antimicrob. Agents 23:362-370. http://dx.doi.org/10.1016/j. ijantimicag.2003.09.021.
19. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing: 22nd informational supplement M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
20. Chiou CS, Liao TL, Wang TH, Chang HL, Liao JC, Li CC. 2004. Epidemiology and molecular characterization of Streptococcus pyogenes recovered from scarlet fever patients in central Taiwan from 1996 to 1999. J. Clin. Microbiol. 42:3998-4006. http://dx.doi.org/10.1128/JCM.42.9.3998-4006.2004.
21. Enright MC, Spratt BG, Kalia A, Cross JH, Bessen DE. 2001. Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect. Immun. 69:2416-2427. http://dx.doi.org/10.1128/IAI.69.4. 2416-2427.2001.
22. O'Brien TF, Stelling J. 2011. Integrated multilevel surveillance of the world's infecting microbes and their resistance to antimicrobial agents. Clin. Microbiol. Rev. 24:281-295. http://dx.doi.org/10.1128/CMR.00021-10.
23. Yan JJ, Wu HM, Huang AH, Fu HM, Lee CT, Wu JJ. 2000. Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in southern Taiwan. J. Clin. Microbiol. 38:2475-2479.
24. Shea PR, Ewbank AL, Gonzalez-Lugo JH, Martagon-Rosado AJ, Martinez-Gutierrez JC, Rehman HA, Serrano-Gonzalez M, Fittipaldi N, Beres SB, Flores AR, Low DE, Willey BM, Musser JM. 2011. Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010. Emerg. Infect. Dis. 17:2010-2017. http://dx.doi.org/10.3201/eid1711.110159.
25. Lepoutre A, Doloy A, Bidet P, Leblond A, Perrocheau A, Bingen E, Trieu-Cuot P, Bouvet A, Poyart C, Levy-Bruhl D. 2011. Epidemiology of invasive Streptococcus pyogenes infections in France in 2007. J. Clin. Microbiol. 49:4094-4100. http://dx.doi.org/10.1128/JCM.00070-11.
26. Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A, Creti R, Ekelund K, Koliou M, Tassios PT, van der Linden M, Straut M, Vuopio-Varkila J, Bouvet A, Efstratiou A, Schalen C, Henriques-Normark B, Jasir A. 2009. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J. Clin. Microbiol. 47: 1155-1165. http://dx.doi.org/10.1128/JCM.02155-08.
27. O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, Beall B, Harrison LH, Reingold A, Van Beneden C. 2007. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin. Infect. Dis. 45:853-862. http://dx.doi.org/10.1086/521264.
28. Chiang-Ni C, Wu AB, Liu CC, Chen KT, Lin YS, Chuang WJ, Fang HY, Wu JJ. 2011. Emergence of uncommon emm types of Streptococcus pyogenes among adult patients in southern Taiwan. J. Microbiol. Immunol. Infect. 44:424-429. http://dx.doi.org/10.1016/j.jmii.2011.04.005.
29. Chiou C-S, Wang Y-W, Chen P-L, Wang W-L, Wu P-F, Wei H-L. 2009. Association of the shuffling of Streptococcus pyogenes clones and the fluctuation of scarlet fever cases between 2000 and 2006 in central Taiwan. BMC Microbiol. 9:115. http://dx.doi.org/10.1186/1471-2180-9-115.
30. Lin JN, Chang LL, Lai CH, Lin HH, Chen YH. 2011. Clinical and molecular characteristics of invasive and noninvasive skin and soft tissue infections caused by group A Streptococcus. J. Clin. Microbiol. 49:3632-3637. http://dx.doi.org/10.1128/JCM.00531-11.
31. Ardanuy C, Domenech A, Rolo D, Calatayud L, Tubau F, Ayats J, Martin R, Linares J. 2010. Molecular characterization of macrolide-and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008). J. Antimicrob. Chemother. 65:634-643. http://dx.doi.org/10.1093/ jac/dkq006.
32. Michos AG, Bakoula CG, Braoudaki M, Koutouzi FI, Roma ES, Pangalis A, Nikolopoulou G, Kirikou E, Syriopoulou VP. 2009. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types. Diagn. Microbiol. Infect. Dis. 64:295-299. http://dx.doi.org/10.1016/j. diagmicrobio.2009.03.004.
33. Chan JC, Chu YW, Chu MY, Cheung TK, Lo JY. 2009. Epidemiological analysis of Streptococcus pyogenes infections in Hong Kong. Pathology 41:681-686. http://dx.doi.org/10.3109/00313020903257723.
34. Le Hello S, Doloy A, Baumann F, Roques N, Coudene P, Rouchon B, Lacassin F, Bouvet A. 2010. Clinical and microbial characteristics of invasive Streptococcus pyogenes disease in New Caledonia, a region in Oceania with a high incidence of acute rheumatic fever. J. Clin. Microbiol. 48:526-530. http://dx.doi.org/10.1128/JCM.01205-09.
35. Seppala H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. 1997. Erythromycin resistance of group A streptococci from throat samples is related to age. Pediatr. Infect. Dis. J. 16:651-656. http://dx.doi.org/10.1097/00006454- 199707000-00006.
36. Blackman Northwood J, Del Grosso M, Cossins LR, Coley MD, Creti R, Pantosti A, Farrell DJ. 2009. Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes isolated between 1999 and 2005. Antimicrob. Agents Chemother. 53:1921-1925. http://dx.doi.org/10.1128/AAC.01065-08.